{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Acetaminophen+%28Ofirmev%29&page=31", "query": { "intervention": "Acetaminophen (Ofirmev)", "page": 31 }, "page_size": 10 }, "pagination": { "page": 31, "page_size": 10, "total_count": 948, "total_pages": 95, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Acetaminophen+%28Ofirmev%29&page=32&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Acetaminophen+%28Ofirmev%29&page=30&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T08:03:48.955Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01364922", "title": "Phase 2 Chronic Low Back Pain Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Low Back Pain" ], "interventions": [ { "name": "hydrocodone/acetaminophen extended release", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 168, "start_date": "2011-06", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2014-01-29", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 17, "location_summary": "Tucson, Arizona • Anaheim, California • Burbank, California + 14 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Burbank", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01364922" }, { "nct_id": "NCT00598559", "title": "Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Pain", "Fever" ], "interventions": [ { "name": "IV Acetaminophen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mallinckrodt", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 213, "start_date": "2008-01", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2016-10-21", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 14, "location_summary": "Arcadia, California • Glendale, California • Laguna Hills, California + 10 more", "locations": [ { "city": "Arcadia", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00598559" }, { "nct_id": "NCT07296770", "title": "An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Postsurgical Pain Management", "Postsurgical Pain, Chronic", "Opioid Use After Surgery" ], "interventions": [ { "name": "TPS-Select", "type": "DEVICE" }, { "name": "Pharmacologic Pain Management", "type": "DRUG" }, { "name": "Interventional Pain Procedures", "type": "PROCEDURE" }, { "name": "Psychological Management and Pain Education", "type": "BEHAVIORAL" }, { "name": "Physical Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "DRUG", "PROCEDURE", "BEHAVIORAL" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 474, "start_date": "2026-10-01", "completion_date": "2029-12-01", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07296770" }, { "nct_id": "NCT06994442", "title": "Optimizing Pain Treatment in Children On Mechanical Ventilation", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Mechanical Ventilation", "Pediatric Acute Respiratory Failure", "Analgesics, Opioid", "Sedation and Analgesia" ], "interventions": [ { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Months to 17 Years" }, "enrollment_count": 644, "start_date": "2025-12-29", "completion_date": "2029-08-31", "has_results": false, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 16, "location_summary": "Little Rock, Arkansas • Washington D.C., District of Columbia • Ann Arbor, Michigan + 13 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06994442" }, { "nct_id": "NCT07252739", "title": "KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Malignant Neoplasm" ], "interventions": [ { "name": "MK-1084", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Cetuximab", "type": "BIOLOGICAL" }, { "name": "Sacituzumab tirumotecan (sac-TMT)", "type": "BIOLOGICAL" }, { "name": "Rescue medication", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2025-12-19", "completion_date": "2032-05-31", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 3, "location_summary": "Clermont, Florida • Fargo, North Dakota • Sioux Falls, South Dakota", "locations": [ { "city": "Clermont", "state": "Florida" }, { "city": "Fargo", "state": "North Dakota" }, { "city": "Sioux Falls", "state": "South Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07252739" }, { "nct_id": "NCT03913559", "title": "Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lymphoblastic Leukemia" ], "interventions": [ { "name": "Inotuzumab ozogamicin", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 5, "start_date": "2019-05-14", "completion_date": "2025-09-15", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 2, "location_summary": "San Diego, California • Memphis, Tennessee", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03913559" }, { "nct_id": "NCT01270659", "title": "Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Fentanyl", "type": "DRUG" }, { "name": "oxycodone/acetaminophen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 60, "start_date": "2011-05", "completion_date": "2014-10", "has_results": true, "last_update_posted_date": "2017-06-20", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 1, "location_summary": "Tulsa, Oklahoma", "locations": [ { "city": "Tulsa", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT01270659" }, { "nct_id": "NCT07227662", "title": "Feasibility, Usability and Preliminary Efficacy of Home-based FES Fro Adhesive Capsulitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Shoulder Adhesive Capsulitis" ], "interventions": [ { "name": "Home based FES in combination with usual therapy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2026-06-01", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07227662" }, { "nct_id": "NCT01759446", "title": "Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Opioid-Related Disorders" ], "interventions": [ { "name": "Placebo taken first", "type": "DRUG" }, { "name": "Generic H/A taken first", "type": "DRUG" }, { "name": "Vycavert taken first", "type": "DRUG" }, { "name": "Generic H/A plus i taken first", "type": "DRUG" }, { "name": "Generic H/A plus p taken first", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Acura Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 44, "start_date": "2013-02", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2018-11-01", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01759446" }, { "nct_id": "NCT04020822", "title": "Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes", "Type 2 Diabetes" ], "interventions": [ { "name": "Guardian Sensor (3)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic MiniMed, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 19, "start_date": "2019-07-29", "completion_date": "2019-08-27", "has_results": true, "last_update_posted_date": "2020-09-16", "last_synced_at": "2026-10-15T08:03:48.955Z", "location_count": 2, "location_summary": "Aurora, Colorado • Atlanta, Georgia", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04020822" } ] }